Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 502

1.

A Closer Examination of the Patient Experience in the Ambulatory Space: A Retrospective Qualitative Comparison of Primary Care With Specialty Care Experiences.

Jurdi ZR, Crosby JF Jr, Harris JE Jr, Harvey JB.

J Ambul Care Manage. 2020 Jan/Mar;43(1):89-97. doi: 10.1097/JAC.0000000000000310.

PMID:
31770188
2.

Occupational Therapy in the ICU: A Scoping Review of 221 Documents.

Costigan FA, Duffett M, Harris JE, Baptiste S, Kho ME.

Crit Care Med. 2019 Dec;47(12):e1014-e1021. doi: 10.1097/CCM.0000000000003999.

PMID:
31738741
3.

Standardizing serial photography for assessing and monitoring vitiligo: a core set of international recommendations for essential clinical and technical specifications.

van Geel N, Hamzavi I, Kohli I, Wolkerstorfer A, Lim HW, Bae JM, Lui H, Harris JE, Pandya AG, Guan STT, Abdallah M, Esmat S, Seneschal J, Speeckaert R, Grine L, Kang HY, Raboobee N, Xiang LF, Bekkenk M, Picardo M, Taieb A.

J Am Acad Dermatol. 2019 Oct 30. pii: S0190-9622(19)32978-0. doi: 10.1016/j.jaad.2019.10.055. [Epub ahead of print]

PMID:
31678332
4.

The Bayesian Approach to Decision Making and Analysis in Nutrition Research and Practice.

Gleason PM, Harris JE.

J Acad Nutr Diet. 2019 Dec;119(12):1993-2003. doi: 10.1016/j.jand.2019.07.009. Epub 2019 Oct 1.

PMID:
31585828
5.

Investigating the feasibility and acceptability of real-time visual feedback in reducing compensatory motions during self-administered stroke rehabilitation exercises: A pilot study with chronic stroke survivors.

Lin S, Mann J, Mansfield A, Wang RH, Harris JE, Taati B.

J Rehabil Assist Technol Eng. 2019 Mar 18;6:2055668319831631. doi: 10.1177/2055668319831631. eCollection 2019 Jan-Dec.

6.

The Role of Memory CD8+ T Cells in Vitiligo.

Riding RL, Harris JE.

J Immunol. 2019 Jul 1;203(1):11-19. doi: 10.4049/jimmunol.1900027. Review.

PMID:
31209143
7.

T-cell positioning by chemokines in autoimmune skin diseases.

Richmond JM, Strassner JP, Essien KI, Harris JE.

Immunol Rev. 2019 May;289(1):186-204. doi: 10.1111/imr.12762. Review.

PMID:
30977191
8.

Validation of a physician global assessment tool for vitiligo extent: Results of an international vitiligo expert meeting.

van Geel N, Wolkerstorfer A, Ezzedine K, Pandya AG, Bekkenk M, Grine L, Van Belle S, Lommerts JE, Hamzavi I, Harris JE, Eleftheriadou V, Esmat S, Kang HY, Kumarasinghe P, Lan CE, Parsad D, Raboobee N, Flora Xiang L, Suzuki T, Prinsen CA, Taieb A, Picardo M, Speeckaert R; participants of the Rome International VGICC /VIS Workshop.

Pigment Cell Melanoma Res. 2019 Sep;32(5):728-733. doi: 10.1111/pcmr.12784. Epub 2019 May 9.

PMID:
30945409
9.

Patient satisfaction and physician productivity in shared medical appointments for vitiligo.

Tkachenko E, Refat MA, Balzano T, Maloney ME, Harris JE.

J Am Acad Dermatol. 2019 Nov;81(5):1150-1156. doi: 10.1016/j.jaad.2019.03.044. Epub 2019 Mar 22.

PMID:
30910662
10.

Does Use of Electronic Alerts for Systemic Inflammatory Response Syndrome (SIRS) to Identify Patients With Sepsis Improve Mortality?

Seetharaman S, Wilson C, Landrum M, Qasba S, Katz M, Ladikos N, Harris JE, Galiatsatos P, Yousem DM, Knight AM, Pearse DB, Blanding R, Bennett R, Galai N, Perl TM, Sood G.

Am J Med. 2019 Jul;132(7):862-868. doi: 10.1016/j.amjmed.2019.01.032. Epub 2019 Mar 2.

PMID:
30831065
11.

Frequency of troponin elevations in patients with influenza infection during the 2017-2018 influenza season.

Harris JE, Shah PJ, Korimilli V, Win H.

Int J Cardiol Heart Vasc. 2019 Jan 30;22:145-147. doi: 10.1016/j.ijcha.2018.12.013. eCollection 2019 Mar.

12.

Examining the relationships between environmental barriers and leisure in community-dwelling individuals living with stroke.

Tang A, Sun B, Pang MY, Harris JE.

Clin Rehabil. 2019 Apr;33(4):796-804. doi: 10.1177/0269215518818234. Epub 2018 Dec 12.

PMID:
30537850
13.

Treatment with Modified Heat Shock Protein Repigments Vitiligo Lesions in Sinclair Swine.

Frisoli ML, Harris JE.

J Invest Dermatol. 2018 Dec;138(12):2505-2506. doi: 10.1016/j.jid.2018.08.003.

14.

Resident Memory and Recirculating Memory T Cells Cooperate to Maintain Disease in a Mouse Model of Vitiligo.

Richmond JM, Strassner JP, Rashighi M, Agarwal P, Garg M, Essien KI, Pell LS, Harris JE.

J Invest Dermatol. 2019 Apr;139(4):769-778. doi: 10.1016/j.jid.2018.10.032. Epub 2018 Nov 10.

PMID:
30423329
15.

Physiotherapy in the neurotrauma intensive care unit: A scoping review.

Newman ANL, Gravesande J, Rotella S, Wu SS, Topp-Nguyen N, Kho ME, Harris JE, Fox-Robichaud A, Solomon P.

J Crit Care. 2018 Dec;48:390-406. doi: 10.1016/j.jcrc.2018.09.037. Epub 2018 Oct 3. Review.

PMID:
30316038
16.

Mouse Model for Human Vitiligo.

Riding RL, Richmond JM, Harris JE.

Curr Protoc Immunol. 2019 Feb;124(1):e63. doi: 10.1002/cpim.63. Epub 2018 Sep 25.

PMID:
30253067
17.

Reliability and validity of the shortened Singapore versions of the Chedoke Arm and Hand Activity Inventory.

Choo SX, Bosch J, Richardson J, Stratford P, Harris JE.

Int J Rehabil Res. 2018 Dec;41(4):297-303. doi: 10.1097/MRR.0000000000000318.

PMID:
30234732
18.

Comprehensive genetic screening: The prevalence of maturity-onset diabetes of the young gene variants in a population-based childhood diabetes cohort.

Johnson SR, Ellis JJ, Leo PJ, Anderson LK, Ganti U, Harris JE, Curran JA, McInerney-Leo AM, Paramalingam N, Song X, Conwell LS, Harris M, Jones TW, Brown MA, Davis EA, Duncan EL.

Pediatr Diabetes. 2019 Feb;20(1):57-64. doi: 10.1111/pedi.12766. Epub 2018 Nov 14.

PMID:
30191644
19.

Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B, Balas MC, van den Boogaard M, Bosma KJ, Brummel NE, Chanques G, Denehy L, Drouot X, Fraser GL, Harris JE, Joffe AM, Kho ME, Kress JP, Lanphere JA, McKinley S, Neufeld KJ, Pisani MA, Payen JF, Pun BT, Puntillo KA, Riker RR, Robinson BRH, Shehabi Y, Szumita PM, Winkelman C, Centofanti JE, Price C, Nikayin S, Misak CJ, Flood PD, Kiedrowski K, Alhazzani W.

Crit Care Med. 2018 Sep;46(9):e825-e873. doi: 10.1097/CCM.0000000000003299.

PMID:
30113379
20.

Executive Summary: Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

Devlin JW, Skrobik Y, Gélinas C, Needham DM, Slooter AJC, Pandharipande PP, Watson PL, Weinhouse GL, Nunnally ME, Rochwerg B, Balas MC, van den Boogaard M, Bosma KJ, Brummel NE, Chanques G, Denehy L, Drouot X, Fraser GL, Harris JE, Joffe AM, Kho ME, Kress JP, Lanphere JA, McKinley S, Neufeld KJ, Pisani MA, Payen JF, Pun BT, Puntillo KA, Riker RR, Robinson BRH, Shehabi Y, Szumita PM, Winkelman C, Centofanti JE, Price C, Nikayin S, Misak CJ, Flood PD, Kiedrowski K, Alhazzani W.

Crit Care Med. 2018 Sep;46(9):1532-1548. doi: 10.1097/CCM.0000000000003259. No abstract available.

PMID:
30113371
21.

International Initiative for Outcomes (INFO) for vitiligo: workshops with patients with vitiligo on repigmentation.

Eleftheriadou V, Hamzavi I, Pandya AG, Grimes P, Harris JE, Huggins RH, Lim HW, Elbuluk N, Bhatia B, Tovar-Garza A, Nahhas AF, Braunberger T, Ezzedine K.

Br J Dermatol. 2019 Mar;180(3):574-579. doi: 10.1111/bjd.17013. Epub 2018 Oct 5.

PMID:
30030843
22.

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.

Richmond JM, Strassner JP, Zapata L Jr, Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, Harris JE.

Sci Transl Med. 2018 Jul 18;10(450). pii: eaam7710. doi: 10.1126/scitranslmed.aam7710.

23.

Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation.

Mande P, Zirak B, Ko WC, Taravati K, Bride KL, Brodeur TY, Deng A, Dresser K, Jiang Z, Ettinger R, Fitzgerald KA, Rosenblum MD, Harris JE, Marshak-Rothstein A.

J Clin Invest. 2018 Jul 2;128(7):2966-2978. doi: 10.1172/JCI98219. Epub 2018 Jun 11.

24.

Cross-cultural adaptation and psychometric evaluation of the Singapore version of the Chedoke Arm and Hand Activity.

Choo SX, Bosch J, Richardson J, Stratford P, Harris JE.

Disabil Rehabil. 2019 Oct;41(21):2570-2577. doi: 10.1080/09638288.2018.1472817. Epub 2018 May 22.

PMID:
29786453
25.

Interrater Reliability of Three Versions of the Chedoke Arm and Hand Activity Inventory.

Johnson D, Harris JE, Stratford P, Richardson J.

Physiother Can. 2018;70(2):133-140. doi: 10.3138/ptc.2016-70.

26.

Motivation in rehabilitation and acquired brain injury: can theory help us understand it?

Kusec A, Velikonja D, DeMatteo C, Harris JE.

Disabil Rehabil. 2019 Sep;41(19):2343-2349. doi: 10.1080/09638288.2018.1467504. Epub 2018 Apr 25.

PMID:
29693464
27.

Psychometric properties of measures of motivation and engagement after acquired brain injury.

Kusec A, DeMatteo C, Velikonja D, Harris JE.

Rehabil Psychol. 2018 Feb;63(1):92-103. doi: 10.1037/rep0000186.

PMID:
29553784
28.

Alopecia areata is a medical disease.

Korta DZ, Christiano AM, Bergfeld W, Duvic M, Ellison A, Fu J, Harris JE, Hordinsky MK, King B, Kranz D, Mackay-Wiggan J, McMichael A, Norris DA, Price V, Shapiro J, Atanaskova Mesinkovska N.

J Am Acad Dermatol. 2018 Apr;78(4):832-834. doi: 10.1016/j.jaad.2017.09.011. No abstract available.

PMID:
29548423
29.

Maternal Exercise Improves the Metabolic Health of Adult Offspring.

Harris JE, Baer LA, Stanford KI.

Trends Endocrinol Metab. 2018 Mar;29(3):164-177. doi: 10.1016/j.tem.2018.01.003. Epub 2018 Feb 3. Review.

30.

Point mutation in p14ARF -specific exon 1β of CDKN2A causing familial melanoma and astrocytoma.

McInerney-Leo AM, Wheeler L, Sturm RA, Tan JM, Harris JE, Anderson L, Jagirdar K, Brown MA, Leo PJ, Soyer HP, Duncan EL.

Br J Dermatol. 2018 Apr;178(4):e263-e264. doi: 10.1111/bjd.16275. Epub 2018 Feb 19. No abstract available.

PMID:
29278422
31.

Building and Crossing the Translational Bridge: 2016 Alopecia Areata Research Summit Highlights.

Kranz D, Ellison A, Mesinkovska NA, Christiano AM, Hordinsky MK, Harris JE.

J Investig Dermatol Symp Proc. 2018 Jan;19(1):S3-S8. doi: 10.1016/j.jisp.2017.10.004.

32.

Vitiligo-like depigmentation in patients receiving programmed cell death-1 inhibitor reflects active vitiligo.

Fukuda K, Harris JE.

J Am Acad Dermatol. 2018 Jan;78(1):e15-e16. doi: 10.1016/j.jaad.2017.07.058. No abstract available.

PMID:
29241799
33.

Lower incidence of myocardial infarction after smoke-free legislation enforcement in Chile.

Nazzal C, Harris JE.

Bull World Health Organ. 2017 Oct 1;95(10):674-682. doi: 10.2471/BLT.16.189894. Epub 2017 Aug 28. Erratum in: Bull World Health Organ. 2017 Nov 1;95(11):792.

34.

Biomechanical study of rod stress after pedicle subtraction osteotomy versus anterior column reconstruction: A finite element study.

Januszewski J, Beckman JM, Harris JE, Turner AW, Yen CP, Uribe JS.

Surg Neurol Int. 2017 Sep 6;8:207. doi: 10.4103/sni.sni_44_17. eCollection 2017.

35.

Impact of intraoperative factor concentrates on blood product transfusions during orthotopic liver transplantation.

Colavecchia AC, Cohen DA, Harris JE, Thomas JM, Lindberg S, Leveque C, Salazar E.

Transfusion. 2017 Dec;57(12):3026-3034. doi: 10.1111/trf.14328. Epub 2017 Sep 28.

PMID:
28960322
36.

Comparison of the sensitivity to change of the Functional Independence Measure with the Assessment of Motor and Process Skills within different rehabilitation populations.

Choo SX, Stratford P, Richardson J, Bosch J, Pettit SM, Ansley BJ, Harris JE.

Disabil Rehabil. 2018 Dec;40(26):3177-3184. doi: 10.1080/09638288.2017.1375033. Epub 2017 Sep 10.

PMID:
28891345
37.

Impact of plain packaging of cigarettes on the risk perception of Uruguayan smokers: an experimental study.

Harris JE, Ares G, Gerstenblüth M, Machin L, Triunfo P.

Tob Control. 2018 Sep;27(5):513-518. doi: 10.1136/tobaccocontrol-2017-053639. Epub 2017 Sep 8.

PMID:
28887428
38.

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.

Liu LY, Strassner JP, Refat MA, Harris JE, King BA.

J Am Acad Dermatol. 2017 Oct;77(4):675-682.e1. doi: 10.1016/j.jaad.2017.05.043. Epub 2017 Aug 18.

39.

Vitiligo: Mechanistic insights lead to novel treatments.

Frisoli ML, Harris JE.

J Allergy Clin Immunol. 2017 Sep;140(3):654-662. doi: 10.1016/j.jaci.2017.07.011. Epub 2017 Aug 1. Review.

PMID:
28778794
40.

Current and emerging treatments for vitiligo.

Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group.

J Am Acad Dermatol. 2017 Jul;77(1):17-29. doi: 10.1016/j.jaad.2016.11.010. Review.

PMID:
28619557
41.

New discoveries in the pathogenesis and classification of vitiligo.

Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group.

J Am Acad Dermatol. 2017 Jul;77(1):1-13. doi: 10.1016/j.jaad.2016.10.048. Review.

PMID:
28619550
42.

Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia.

Reuben J, Donegan N, Wortmann G, DeBiasi R, Song X, Kumar P, McFadden M, Clagon S, Mirdamadi J, White D, Harris JE, Browne A, Hooker J, Yochelson M, Walker M, Little G, Jernigan G, Hansen K, Dockery B, Sinatro B, Blaylock M, Harmon K, Iyengar P, Wagner T, Nelson JA; HARP Study Team.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):921-929. doi: 10.1017/ice.2017.110. Epub 2017 Jun 15.

PMID:
28615088
43.

An in vitro evaluation of sagittal alignment in the cervical spine after insertion of supraphysiologic lordotic implants.

Blaskiewicz DJ, Harris JE, Han PP, Turner AW, Mundis GM.

Eur Spine J. 2018 Feb;27(2):433-441. doi: 10.1007/s00586-017-5110-y. Epub 2017 May 13.

PMID:
28501956
44.

Crossover Designs in Nutrition and Dietetics Research.

Harris JE, Raynor HA.

J Acad Nutr Diet. 2017 Jul;117(7):1023-1030. doi: 10.1016/j.jand.2017.03.017. Epub 2017 May 4.

PMID:
28479137
45.

Optimizing Vitiligo Management: Past, Present, and Future.

Harris JE.

Dermatol Clin. 2017 Apr;35(2):xi. doi: 10.1016/j.det.2017.01.001. No abstract available.

PMID:
28317535
46.

Vitiligo Pathogenesis and Emerging Treatments.

Rashighi M, Harris JE.

Dermatol Clin. 2017 Apr;35(2):257-265. doi: 10.1016/j.det.2016.11.014. Review.

47.

Chemical-Induced Vitiligo.

Harris JE.

Dermatol Clin. 2017 Apr;35(2):151-161. doi: 10.1016/j.det.2016.11.006. Review.

48.

Mixed-Methods Research in Nutrition and Dietetics.

Zoellner J, Harris JE.

J Acad Nutr Diet. 2017 May;117(5):683-697. doi: 10.1016/j.jand.2017.01.018. Epub 2017 Mar 8.

PMID:
28284525
49.

Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.

Strassner JP, Rashighi M, Ahmed Refat M, Richmond JM, Harris JE.

J Am Acad Dermatol. 2017 May;76(5):847-855.e5. doi: 10.1016/j.jaad.2016.12.021. Epub 2017 Mar 1.

50.

The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo.

Mohammad TF, Al-Jamal M, Hamzavi IH, Harris JE, Leone G, Cabrera R, Lim HW, Pandya AG, Esmat SM.

J Am Acad Dermatol. 2017 May;76(5):879-888. doi: 10.1016/j.jaad.2016.12.041. Epub 2017 Feb 16.

PMID:
28216034

Supplemental Content

Loading ...
Support Center